We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
McWilliams, J.M. and Schwartz, A.L., “Focusing on High-Cost Patients — The Key to Addressing High Costs?”New England Journal of Medicine376 (2017): 807-809.CrossRefGoogle Scholar
2
Cynamon, J.K., “Normative Concerns with High-Risk Pools,”Journal of Law, Medicine & Ethics46, no. 3 (2018): 766-772.CrossRefGoogle Scholar
Hwang, W., LaClair, M., Camacho, F., and Paz, H., “Persistent High Utilization in a Privately Insured Population,”The American Journal of Managed Care21 (2015): 309-316.Google Scholar
Pringle, J.L., Boyer, A., Conklin, M.H., McCullough, J.W. and Aldridge, A., “The Pennsylvania Project: Pharmacist Intervention Improved Medication Adherence and Reduced Health Care Costs,”Health Affairs33 (2014): 1444-1452.Google Scholar
7
Schurrer, J., O'Malley, A., Wilson, C., McCall, N., and Jain, N., “Evaluation of the Diffusion and Impact of the Chronic Care Management (CCM) Services: Final Report, 50131” (November 2, 2017).Google Scholar
8
Porter, M.E., Kramer, M.R. and Sesia, A., “Discovery Limited,”Harvard Business School Case 715-423 (2014): 1-18.Google Scholar